|
|
| Name
: |
Max E. Link |
| Title
: |
Chairman of the Board |
| Since: |
2002 |
|
|
|
|
| Name
: |
Steven A. Kriegsman |
| Title
: |
President, Chief Executive Officer, Director |
| Since: |
07/2002 |
|
|
|
|
| Name
: |
Marvin R. Selter |
| Title
: |
Vice Chairman of the Board |
| Since: |
07/29/2004 |
|
|
|
|
| Name
: |
Mitchell Fogelman |
| Title
: |
Chief Financial Officer |
| Since: |
09/12/2007 |
|
|
|
|
| Name
: |
David J. Haen |
| Title
: |
Vice President, Business Development |
| Since: |
|
|
|
|
|
| Name
: |
Jack R. Barber |
| Title
: |
Senior Vice President - Drug Development, Chief Scientific Officer |
| Since: |
07/22/2004 |
|
|
|
|
| Name
: |
Chung Shi Ng |
| Title
: |
Senior Vice President - Research and Development |
| Since: |
04/2007 |
|
|
|
|
| Name
: |
Benjamin S. Levin |
| Title
: |
Vice President - Legal Affairs, General Counsel, Corporate Secretary |
| Since: |
07/26/2004 |
|
|
|
|
| Name
: |
John C. Caloz |
| Title
: |
Chief Accounting Officer |
| Since: |
10/26/2007 |
|
|
|
|
| Name
: |
Scott Wieland, Ph.D. |
| Title
: |
Vice President, Clinical and Regulatory Affairs |
| Since: |
|
|
|